|  |  | Resistance classification | ||
---|---|---|---|---|---|
Gene | Codons | Number by drug resistance category and rpoB gene loci | Gene region | Absent wild type probe | DNA sequencing results |
rpoB | 531 (14) | 9, 1, 1, 1 | 531–533 | WT8a | TCG-TGG (Ser-Trp), TCG-TGC (Ser-Cys), TCG-TAT (Ser-Tyr), TCG-TTT (Ser-Phe) |
531&526 | 1 | 531–533 | WT8a | TCG-TGG (Ser-Trp) & CAC-TAC (His-Tyr) | |
531&605 | 1 | – | – | TCG-TTC (Ser-Phe) & TAC-GAC (Tyr-Asp) | |
526 (5) | 1, 1 | 525–530 | WT7 | CAC-TGC (His-Cys), CAC-AAC (His-Asp) | |
526, 506&531 | 1 | 525–530 | – | CAC-CTC (His-Leu), TTC-TTA (Phe-Leu) & TCG-TGG (Ser-Trp) | |
526&528 | 1 | – | WT7a | CAC-CTC (His-Leu) & CGC-TGC (Arg-Cys) | |
526&506 | 1 | – | WT7 | CAC-CTC (His-Leu) & TTC-TTA (Phe-Leu) | |
516 (12) | 1 | 513–517 | WT3a | Ins CTT (Leu) b/w 514–515 | |
– | 1 |  | WT3 | GAC-TAC (Asp-Tyr) | |
– | 3, 6 | 513–517 & 516–519 | WT3&4 | GAC-GTC (Asp-Val), GAC-TAC (Asp-Tyr) | |
509&516 | 1 | 506–509, 513–517 & 516–519 | WT 1,3&4 | AGC-ATC (Glu-His), GAC-TAC (Asp-Tyr) | |
516 | 1 | – | WT4a | GAC-GTC (Asp-Val) | |
513 (4) | 2,1,2 | Â | WT3&4 | CAA-CCA (Gln-Pro), CAA-GAA (Gln-Glu), CAA-GTA (Gln-Val) | |
513&526 | 1, 1 | – | WT3&4 | CAA-CTA (Gln-Leu) & CAC-CAG (His-Gln) | |
 | 1 | – | WT3&4 | Ins CTT (Leu) at 513–514 | |
515&572 | 1 | 513–517 | WT3a | ATG-CTG (Met-Leu) & ATC-TTC (Ile-Phe) | |
511 (3) | 1, 2, 1 | 510–513 | WT2 | CTG-CCG (Leu-Pro), Ins CCG (Pro) at 511–513, Ins GAG (Glu) at 511–512 | |
518 (3) | 2 | 518–522 | WT5 | AAC-GAC (Asn-Asp) | |
– | 1 | 518–522 & 522–525 | WT5&6 | Del AAC (Thr) | |
518 | 1 | 516–520 | WT4 | AAC-GAC (Asn-Asp) |